Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial

Infliximab and ciclosporin are of similar efficacy in treating acute severe ulcerative colitis, but there has been no comparative evaluation of their relative clinical effectiveness and cost-effectiveness.In this mixed methods, open-label, pragmatic randomised trial, we recruited consenting patients...

Full description

Bibliographic Details
Main Authors:	Williams, J, Alam, M, Alrubaiy, L, Arnott, I, Clement, C, Cohen, D, Gordon, J, Hawthorne, A, Hilton, M, Hutchings, H, Jawhari, A, Longo, M, Mansfield, J, Morgan, J, Rapport, F, Seagrove, A, Sebastian, S, Shaw, I, Travis, S, Watkins, A
Format:	Journal article
Language:	English
Published:	Elsevier 2016

Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial

Similar Items